Description As cybersecurity expectations continue to evolve across both FDA and EU MDR frameworks, many medical device submissions face avoidable deficiencies and delays that impact timely market access. We'll explores practical, regulator-aligned strategies to proactively address cybersecurity requirements in both regions, reduce review cycles, and increase the likelihood of first-pass success. Gain insight into common gaps and documentation best practices submissions to meet both FDA and EU expectations with confidence.
Learning Objectives:
Identify the most common cybersecurity deficiencies cited by FDA reviewers and EU notified bodies
Understand key differences and overlaps between US and EU cybersecurity expectations for medical devices
Develop a proactive approach to cybersecurity that improves submission quality and increases likelihood of first-pass approval
.png)
